Dimensional Fund Advisors
CLRB icon

Dimensional Fund Advisors’s Cellectar Biosciences CLRB Stock Holding History

Dimensional Fund Advisors’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,033
Closed -$73K – 3258
2025
Q3 		$73K Buy
+13,033
New +$64.6K ﹤0.01% 3220
2021
Q2 		– Sell
-71
Closed -$34K – 3464
2021
Q1 		$34K Sell
71
-36
-34% -$21.4K ﹤0.01% 3399
2020
Q4 		$67K Buy
+107
New +$49.2K ﹤0.01% 3299
2019
Q3 		– Sell
-34
Closed -$22K – 3421
2019
Q2 		$22K Hold
34
– – ﹤0.01% 3451
2019
Q1 		$24K Hold
34
– – ﹤0.01% 3428
2018
Q4 		$16K Hold
34
– – ﹤0.01% 3439
2018
Q3 		$31K Buy
+34
New +$40K ﹤0.01% 3406

Other funds holding CLRB

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors's CLRB Position: Q4 2025 in Review

Dimensional Fund Advisors sold out of Cellectar Biosciences (CLRB) in Q4 2025, closing a stake of 13,033 shares — an estimated $73K sold.

Dimensional Fund Advisors first reported a position in CLRB in Q3 2018 and held it in 7 quarters. The position peaked at $73K in Q3 2025. 20 funds tracked by Wall St. Rank hold CLRB as of Q4 2025.

  • Dimensional Fund Advisors reported no remaining Cellectar Biosciences position as of Q4 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 13,033 Cellectar Biosciences shares in Q4 2025, an estimated $73K.
  • Dimensional Fund Advisors first reported a position in Cellectar Biosciences in Q3 2018 and held it in 7 quarters.
  • Dimensional Fund Advisors's Cellectar Biosciences position peaked at $73K in Q3 2025.
  • 20 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q4 2025.

Based on Dimensional Fund Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.